81216 Brca2 gene full seq alys
Also known as: BRCA2 sequencing, BRCA2 full analysis
Complete sequence analysis of the BRCA2 gene to identify point mutations and small indels associated with hereditary breast and ovarian cancer.
In Plain Language
breast cancer gene test; hereditary cancer genetic testing
Clinical Context
Employed to comprehensively screen for BRCA2 mutations in high-risk individuals for hereditary breast and ovarian cancer syndrome.
RVU Information
CPT 81216 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81216?
CPT 81216 (Brca2 gene full seq alys) is a Pathology & Lab code. Complete sequence analysis of the BRCA2 gene to identify point mutations and small indels associated with hereditary breast and ovarian cancer.
Who uses CPT code 81216?
CPT 81216 is used by Oncology, Genetics, Pathology. Employed to comprehensively screen for BRCA2 mutations in high-risk individuals for hereditary breast and ovarian cancer syndrome.
When is CPT 81216 used?
Employed to comprehensively screen for BRCA2 mutations in high-risk individuals for hereditary breast and ovarian cancer syndrome.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.